Genomics

Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) Raw Data

The Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) study provides transcriptomic and chromatin accessibility data from single nuclei isolated from postmortem brain tissue from individuals spanning the Alzheimer's disease spectrum. The study supports investigation of cellular and molecular changes associated with Alzheimer's disease progression and includes data generated as part of the broader SEA-AD effort to characterize brain cell types, disease-associated cellular states, and related neuropathology.

Listed for discovery. Access is provided by the original publisher under its terms.

Data coverage

Access & permitted use

Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.

https://adknowledgeportal.synapse.org/Explore/Studies/DetailsPage/StudyDetails?Study=syn26223298Acknowledgement

Need help sourcing data?

Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.

Request sourcing help

Related data sources

Clinical trialsOpen API

ClinicalTrials.gov Study Records

Registered clinical studies, recruitment status, interventions, conditions, sponsors and reported results. Searchable structured records available through the ClinicalTrials.gov API.

ClinicalTrials.gov / U.S. National Library of Medicine

Drug safetyOpen API

FDA Drug Adverse Event Reports

Publicly releasable drug adverse event and medication error reports drawn from FAERS, provided as queryable JSON through openFDA.

U.S. Food and Drug Administration

Population healthPublic download

CDC BRFSS 2025 Survey Microdata

Annual U.S. behavioral risk-factor survey covering chronic conditions, health behaviors and preventive care. The 2025 release contains 356,158 survey records.

Centers for Disease Control and Prevention